Natera Facing Investor Class Action Over Genetic Test Accuracy Concerns
April 28, 2022 Natera faces a proposed class action that alleges investors were injured financially as a result of stock-price drops linked to prenatal test accuracy concerns.
Lawsuit Filings
Natera Hit with Class Action Over Allegedly Inaccurate Prenatal Screening Tests
February 21, 2022 A proposed class action alleges Natera’s prenatal tests are not as reliable as the company claims.
Class Action Alleges Customers Received Surprise Bills for Natera Genetic Tests
December 8, 2021 Natera faces a class action that claims it has misrepresented the costs of its tests and hit thousands of patients with unexpected, “extremely high” bills.